ArticleCancers2025

A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors.

Cristina Aparicio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.